CV Lattes
ResearcherID
ORCID
Google Scholar Citations
Universidade Estadual de Campinas (UNICAMP). Faculdade de Ciências Médicas (FCM) (Institutional affiliation from the last research proposal) Birthplace: Brazil
He obtained his degree in Medicine from the University of São Paulo (FMRP-USP, 1981) and made a medical residency (Medical and Cardiology Clinic, 1981-185) at the HC of the FMRP itself. He was an auxiliary teacher of teaching in cardiovascular physiology and cardiology with the FCM of Santos (1985-1994). He has a master's degree in Medicine (Cardiology) from the Federal University of São Paulo and a doctorate in Medical Clinic from the State University of Campinas. From 06/1995 to 09/1997, he was a Sharp Dohme Foundation fellow and did his clinical and cardiovascular pharmacology postdoctoral under Prof. Terrence Blaschke's supervision. Upon returning to the country (10/1997), he became a Doctor Professor at FCM-UNICAMP (Pharmacology) and Free Tee's (2004). Since 2010, he's been a full professor at the Medical Clinic Department, where he does cardiology care and health science research and teaches cardiovascular and geriatric undergraduates and cardiovascular pharmacology postgraduates. From 07/2006 to 08/2007, he served as a teacher-council (Prof. Antonio Coca/Fapesp) at the University of Barcelona Hospital de Clínicas (España). He has coordinated the Cardiovascular Pharmacology and Resistant Hypertension Ambulatory of HC-Unicamp since 1997. He has been a CNPq researcher (1a) since 1997 and is currently a member of this body's Advisor of Medicine Committee (2018-ATU).Member of the Journal Editorial Corps of Human Hypertension (Springer-Nature Ed). He is a member of the American Heart Association (AHA), American Society of Hypertension (ASH), European Society of Hypertension (ESH), European Society of Cardiology (ESC), International Society of Hypertension (ISH), Sociedad Española de Cardiology (SEC) and American College of Physicians (ACP), besides the Brazilian Societies of Hypertension (SBH), Brazilian Cardiology (DHA-SBC), Cardiology of the State of São Paulo (SOCESP). Expertise in Internal Medicine, focusing on cardiovascular disease, including cardiovascular pharmacology, hypertension, and refractory/resistant hypertension. From 2011 to 2016, he coordinated "Primary Principles of Clinical Research" (PPCR Course of Harvard University) at Unicamp. Won the Unicamp "Zeferino Vaz" award in 2012. From 09/2015 to 09/2016, he remained as a teacher-invited (Prof. Felipe Fregni) at Spaulding Hospital, an affiliate of Harvard Medical School in Boston (Ma-USA). In 2017, it resumed its teaching, research and assistance activities with its institution (Unicamp). During this period, he worked at the CNPq Medicine Advisor Committee (2020-2022), the Board of Directors of the SOCESP (2910-2921) and as a member of the FCM-Unicamp Teacher Commission (CCD) (2020-ATU). It has almost 300 complete international scientific articles published, 20 national and 14 book chapters. He is an opinion of 18 international journals and federal research promotion agencies such as FAPESP and CNPq. It is currently dedicated to studying resistant hypertension from the prism of chaos theory and mathematics. Orcid ID: 0000-0001-6330-697X (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Increased blood pressure (BP) levels are both the cause and the consequence of the hardening of large and medium-sized arteries, central, which is an important indicator of morbidity and mortality in several diseases, especially in Arterial Hypertension (AH). In this, stiffness results from remodeling of the arterial wall caused by biomechanical stimuli against biochemical, cellular and t…
Obesity affects more than 400 million subjects in the world and projections for the next 15 years predict an overall prevalence of up to 20%. In developing countries, such as Brazil a rapid nutritional transition provided by the recent economical growth has led to a unique condition on which the malnourished persist in parallel with an increasing number of obese subjects. It is expected t…
The mechanisms of resistance to antihypertensive treatment are not fully elucidated, but it has been associated to hyperactivity of sympathetic nervous system (SNS). Invasive therapies have been developed for the RHTN treatment, but SNS hyperactivity remains as a challenge in clinical practice. Thus, the use of cerebral stimulation techniques, such as non-invasive transcranial direct curr…
Resistant Hypertension is characterized as the presence of hypertension and concomitant use of three different classes of antihypertensive drugs with at least one of these agents been a diuretic. In 2008, the American Heart Association (AHA) added to this hypertensive group those patients who require four or more classes of antihypertensive drugs to achieve blood pressure control. Recentl…
(Only some records are available in English at this moment)
Resistant Arterial Hypertension (RAH) is a complex and multifactorial syndrome, with hyperactivity of the Sympathetic Nervous System (SNS) and reduction of vagal activity being considered some of the main causes of refractoriness to treatment. Seen from the outside, it resembles a complicated (see lat. "Cum plicate") or complex disease (see lat. "Cum plexus"), Chaotic with the participati…
Resistant Hypertension (RHTN) is defined as blood pressure (BP) that remains above goal (SBP e 140mmHg and/or DBP e 90mmHg) in spite of the concurrent use of 3 antihypertensive agents of different classes prescribed at optimal doses and ideally, one of the 3 agents should be a diuretic. It has complex physiopathological mechanisms that are not completely elucidated, which makes it a disea…
Resistant hypertension (RH) is a multifactorial disease associated with other clinical conditions such as type 2 diabetes (DM2), obesity and dyslipidemia, as well as target-organ damage, which increases the risk of cardiovascular events. Therefore, new therapeutic strategies in an attempt to achieve blood pressure control and reduce cardiovascular risk of these patients have been studied.…
Resistant hypertension (RH) is defined as the condition whose the blood pressure (BP) pressure remains above the target despite the concurrent use of three or more classes of antihypertensive drugs in optimal doses, and if possible a diuretic. The mechanisms of resistance to antihypertensive treatment are not fully elucidated, and may be modulated by several related factors such as obesit…
(Only some records are available in English at this moment)
Resistant hypertension (RHTN) is defined as high blood pressure (BP) in spite of concurrent use of three or more antihypertensive drugs of different classes, combined at optimal doses and including a diuretic. The mechanisms of resistance to antihypertensive treatment is a multifactorial condition not fully elucidated, but it has been associated to hyperactivity of sympathetic nervous sys…
Resistant hypertension (RH) is a multifactorial condition defined as high blood pressure (BP) in spite of concurrent use of three or more antihypertensive drugs of different classes, combined at optimal doses and including a diuretic. The mechanisms of resistance to antihypertensive treatment are not fully elucidated, but it has been associated to hyperactivity of sympathetic nervous syst…
Genetic polymorphisms of matrix metalloproteinases in resistant hypertension CEPID Prof. Dr. Heitor Moreno Junior Faculdade de Ciências Médicas-UNICAMP Prof. Dr. Felipe Fregni Harvard Medical School. Abstract. Resistant hypertension (RH) is characterized by high blood pressure in spite of concurrent use of three antihypertensive agents of different classes, combined at optimal doses and i…
(Only some records are available in English at this moment)
| 2 / 2 | Ongoing grants |
| 14 / 4 | Completed research grants |
| 1 / 1 | Ongoing scholarships in Brazil |
| 26 / 14 | Completed scholarships in Brazil |
| 5 / 5 | Completed scholarships abroad |
| 48 / 26 | All research grants and scholarships |
| Associated processes | |